![](https://lumacina.com.au/wp-content/uploads/2023/04/rudy-flach-1-762x700.jpg)
Rudy Flach
- Senior Vice President – Research & Development
Rudy Flach is Senior Vice President of Research & Development at Lumacina. Rudy brings over 24 years of experience in drug product development, analytical development, clinical support, commercial manufacturing, and regulatory strategies for NDA/ANDA submissions with an extensive focus on sterile injectables.
Rudy will oversee the company’s R&D development programs across all drug dosage platforms focusing on core development in formulation, analytical, manufacturing tech transfer and regulatory affairs strategies.
Rudy has extensive scientific leadership and management experience in creating and managing high performing technical teams to deliver high-quality solutions. As a Subject Matter Expert (SME) in formulation development, Rudy has developed numerous complex drug product formulations and has received over 30 ANDA/NDA approvals.
Rudy has held various positions at Baxter Healthcare, Teva Pharmaceuticals, Avrio Biopharmaceuticals, Alcami, Exova, B. Braun, Gilead Sciences, and Custopharm, Inc. Rudy holds a B.Sc. in Chemistry from the University of California, Irvine and a M.Sc. in Organic Chemistry from California State University, Fullerton.